Claim

Model ledger-default@0.1.0 ledger-strict@0.1.0 ledger-default@0.2.0 ledger-strict@0.2.0 ledger-default@0.3.0 (default) ledger-strict@0.3.0 Snapshot seq

Topics

Vaccines · 1efd24fe Public health · 1efd24fe

Assessment

Why?

Strongest counted support: The primary study reports adjusted effectiveness estimates for moderate and severe rotavirus gastroenteritis. weight 2.000000 evidence

Review gaps: qualifiers reviewed, opposing search done, independence reviewed

What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Unresolved.

Show calculation

Your view

Registered views

Checked as part of

Statements this claim was broken out of. The claim is scored on its own; a statement's reading only counts its claims.

• “A 2026 Nature Communications test-negative case-control analysis in India estimated adjusted effectiveness of the three-dose ROTASIIL rotavirus vaccine...” · 3 claims · 29 September 2026

Evidence for

• The primary study reports adjusted effectiveness estimates for moderate and severe rotavirus gastroenteritis.

  From Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Primary severity-stratified estimate.

Evidence against

None.

Qualifications

• The passage directly reports 56% effectiveness against moderate RVGE and 54% against severe RVGE, but omits dose count, age range, and study setting.

  From Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Both requested effectiveness values and outcomes are explicit; the population and regimen qualifiers are absent.

• The estimates are adjusted observational test-negative results pooled across 32 hospitals in seven Indian states, with wide confidence intervals and 638 ELISA-positive cases among 2,243 children.

  From Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  The point estimates are not from a randomized trial; they apply to the defined hospitalized 3–23-month cohort and completed three-dose series.

Suppressed as dependent

None.

Inferences

Concluded from

None.

Used as a premise in

None.

An inference is interpretation, not evidence: it never changes the assessment of its conclusion. Each premise is a claim with its own evidence.

Threads

None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.

Claim edges

None. Edges are stored and displayed; v0.1 does not propagate probability across them.

Review checklist

Review checks: 1 of 4

2 checks by this claim's own author, alongside the independent review above. 1 QUALIFIER CHECK · 1 EVIDENCE VERIFICATION. A check by the person who recorded a claim does not raise its review coverage.

Check	Done	By
qualifiers reviewed	no
opposing search done	no
independence reviewed	no
primary source reviewed	yes	b54d4931, 2ae7d2c6, fd5b055b

Summary

Contribution history

seq	event	detail
19430	APPENDED
19431	ACCEPT	AUTOMATIC_AFTER_VALIDATION
19446	LINK_EVIDENCE	by 1efd24fe (accepted)
24778	TASK_RESULT	by 1efd24fe (accepted)
25981	TASK_RESULT	by 1efd24fe (accepted)